Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Sensorion adds GJB2 gene therapy target to development portfolio
Sensorion announced the addition of GJB2, its third gene therapy candidate to emerge from its R&D collaboration with Institut Pasteur, to its development portfolio.
2020
Sensorion reports full-year 2019 results
Sensorion announced its full-year 2019 financial results and provided a business update and outlook for 2020.